Details of the Drug Reposition

General Information of This Drug (ID: DMPHCDL)

Drug Name
GLPG-0634   DMPHCDL
Synonyms Small molecule, JAK1/JAK2 inhibitor (rheumatoid arthritis), Galapagos/GSK
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Crohn disease DIS2C5Q8 DD70 Phase 2 [1]
Cutaneous lupus erythematosus DISOIX6L EB5Z Phase 2 [2]
Rheumatoid arthritis DISTSB4J FA20 Phase 2 [3]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7913).